Is Algernon Pharmaceuticals Inc. (AGN.CN) a Buy, Sell, or Hold?
CNQ : AGN.CN
Algernon Pharmaceuticals Inc.
$0.045 CAD
$0 (0.0%)
- Volume
- 2.17K
- Average Volume
- 5.17K
- Market Capitalization
- $157.52K
- P/E Ratio
- -0.07
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.00
- Year Low
- $0.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.25
Company Overview
CNQ
Christopher J. Moreau
Biotechnology
Healthcare
AGN.CN
5
CA
CAD
Liquidity Metrics
0.00
0.25
0.25
0.09
0.00
Sales & Valuation
-$
0.00
0.06
-0.12
-0.36
Profitability
-$0.582
-$1.72M
0.00%
0.00%
-92.73%
-39.22%
P/E Metrics
-0.07
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Poll Results
About Algernon Pharmaceuticals Inc. (CNQ:AGN.CN) Stock
Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company dedicated to discovering and developing new treatments. Their research and development efforts concentrate on a range of serious conditions, including non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19, operating across Canada and Australia. The company's primary drug candidate, NP-120, acts as an N-methyl-d-aspartate (NMDA) receptor glutamate antagonist. This compound specifically targets the NMDA-type subunit 2B (Glu2NB) and also demonstrates agonist activity for the Sigma-1 receptor, a chaperone protein elevated during endoplasmic reticulum stress. Furthermore, Algernon is advancing AP-188, a ... psychedelic agent from the tryptamine family, for treating ischemic stroke in humans. Preclinical investigations for AP-188, as part of their stroke clinical research program, are underway through a collaboration with Charles River Laboratories. Established in 2015, Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
Frequently Asked Questions
-
What is the current Algernon Pharmaceuticals Inc. (AGN.CN) stock price?
-
Algernon Pharmaceuticals Inc.(CNQ:AGN.CN) stock price is $0.045 in the last trading session. During the trading session, AGN.CN stock reached the peak price of $1 while $0.045 was the lowest point it dropped to. The percentage change in AGN.CN stock occurred in the recent session was 0.0% while the dollar amount for the price change in AGN.CN stock was $0.
-
AGN.CN's industry and sector of operation?
-
The CNQ listed AGN.CN is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AGN.CN?
-
James F. Kinley | Chief Financial Officer & Corporate Secretary
Christopher Bryan | Vice President of Research & Operations
Christopher J. Moreau | Chief Executive Officer & Director
|
| -
How many employees does AGN.CN have?
-
Number of AGN.CN employees currently stands at 5. AGN.CN operates from 700 West Pender Street, Vancouver, BC V6C 1G8, CA.
-
Link for AGN.CN official website?
-
Official Website of AGN.CN is: https://algernonpharmaceuticals.com
-
How do I contact AGN.CN?
-
AGN.CN could be contacted at phone #+1 604 398 4175 and can also be accessed through its website. AGN.CN operates from 700 West Pender Street, Vancouver, BC V6C 1G8, CA.
-
How many shares of AGN.CN are traded daily?
-
The average number of AGN.CN shares traded daily for last 3 months was 5.17K.
-
What is the market cap of AGN.CN currently?
-
The market value of AGN.CN currently stands at $157.52K with its latest stock price at $0.045